Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price

Regencell Bioscience Holdings Limited (RGC) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $0.68 per share as of 2025-06-30, per its 20-F filed 2025-10-31.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2025-10-31

2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.68.
2024-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.26; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed $9.96.
2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $9.94.
2023-06-29: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $0.26.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price as first filed
2025-06-30	$0.68 20-F · filed 2025-10-31
2024-06-30	$0.26 20-F · filed 2025-10-31	$9.96 20-F · filed 2024-10-25
2023-06-30	$9.94 20-F · filed 2024-10-25
2023-06-29	$0.26 20-F · filed 2025-10-31
2022-06-30	$9.86 20-F · filed 2024-10-25
2022-01-01	$31.85 20-F · filed 2022-10-31
2021-06-30	$9.50 20-F · filed 2023-10-27
2021-06-09	$9.50 20-F · filed 2022-10-31